Zura Bio Limited Statistics
Share Statistics
Zura Bio Limited has 65.29M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 65.29M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 699 |
| FTD / Avg. Volume | 0.14% |
Short Selling Information
The latest short interest is 1.75M, so 2.68% of the outstanding shares have been sold short.
| Short Interest | 1.75M |
| Short % of Shares Out | 2.68% |
| Short % of Float | 3.72% |
| Short Ratio (days to cover) | 5.43 |
Valuation Ratios
The PE ratio is -2.38 and the forward PE ratio is -6.14.
| PE Ratio | -2.38 |
| Forward PE | -6.14 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 2.42 |
| P/FCF Ratio | -6.24 |
| PEG Ratio | n/a |
Enterprise Valuation
Zura Bio Limited has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.
| Current Ratio | 4.97 |
| Quick Ratio | 4.97 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.02% and return on capital (ROIC) is -78.48%.
| Return on Equity (ROE) | -1.02% |
| Return on Assets (ROA) | -0.6% |
| Return on Capital (ROIC) | -78.48% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -4.31M |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -203.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -50% in the last 52 weeks. The beta is 0.14, so Zura Bio Limited's price volatility has been higher than the market average.
| Beta | 0.14 |
| 52-Week Price Change | -50% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 3.79 |
| Relative Strength Index (RSI) | 25.88 |
| Average Volume (20 Days) | 496.77K |
Income Statement
In the last 12 months, Zura Bio Limited had revenue of $0 and earned -$60.36M in profits. Earnings per share was $-2.09.
| Revenue | 0 |
| Gross Profit | 0 |
| Operating Income | -62.64M |
| Net Income | -60.36M |
| EBITDA | -60.56M |
| EBIT | - |
| Earnings Per Share (EPS) | -2.09 |
Balance Sheet
The company has $99.81M in cash and $0 in debt, giving a net cash position of $99.81M.
| Cash & Cash Equivalents | 99.81M |
| Total Debt | 0 |
| Net Cash | 99.81M |
| Retained Earnings | -103.49M |
| Total Assets | 189.07M |
| Working Capital | 170.73M |
Cash Flow
In the last 12 months, operating cash flow was -$15.05M and capital expenditures -$8.00M, giving a free cash flow of -$23.05M.
| Operating Cash Flow | -15.05M |
| Capital Expenditures | -8.00M |
| Free Cash Flow | -23.05M |
| FCF Per Share | -0.7 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
ZURA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -91.27% |
| FCF Yield | -15.43% |
Analyst Forecast
The average price target for ZURA is $15, which is 555% higher than the current price. The consensus rating is "Buy".
| Price Target | $15 |
| Price Target Difference | 555% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Scores
| Altman Z-Score | 3.88 |
| Piotroski F-Score | 2 |